申请人:Hoffmann-La Roche Inc.
公开号:US05329002A1
公开(公告)日:1994-07-12
There are presented antibacterial cephalosporins having broad antimicrobial activity as well as intermediates for their formation, such compounds having the formula ##STR1## wherein R is hydrogen or a carboxylic acid-protecting group; R.sub.1 is a substituted piperazinium group of the formula ##STR2## in which Q represents a substituted quinolinyl or naphthyridinyl group and the piperazine nucleus may be optionally substituted with one or more lower alkyl groups; R.sub.2 is selected from the group consisting of hydrogen, lower alkoxy, lower alkylthio and amido; R.sub.3 is hydrogen or an acyl group; and m is 0, 1 or 2, preferably 0; as well as the corresponding readily hydrolyzable esters, pharmaceutically acceptable salts and hydrates of these compounds.
本发明提供了具有广谱抗微生物活性的抗菌头孢菌素以及它们的中间体,这些化合物具有以下式子:##STR1## 其中R为氢或羧基保护基;R.sub.1为以下式子的取代哌嗪基:##STR2## 其中Q代表取代的喹啉基或萘啉基,哌嗪核可以选择性地取代一个或多个较低的烷基基团;R.sub.2选自氢、较低的烷氧基、较低的烷基硫基和酰胺基的群;R.sub.3为氢或酰基基团;m为0、1或2,优选为0;以及这些化合物的相应易于水解的酯、药学上可接受的盐和水合物。